Autoimmune Basis for Postural Tachycardia Syndrome
Status:
Enrolling by invitation
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if some people with postural tachycardia syndrome (POTS)
have higher levels of immune proteins (autoantibodies) directed against receptors of the
autonomic nervous system, and if these autoantibodies make a difference in their POTS
symptoms. The investigators also want to see if the levels of these autoantibodies stay the
same over time.
Phase:
N/A
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center